| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.64.2.185 |
| P698 | PubMed publication ID | 17296833 |
| P50 | author | Frauke Zipp | Q21259942 |
| Carmen Infante-Duarte | Q55109623 | ||
| P2093 | author name string | Orhan Aktas | |
| Robert Nitsch | |||
| Oliver Ullrich | |||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 185-189 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Neuronal damage in brain inflammation | |
| P478 | volume | 64 |
| Q37144845 | Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis |
| Q28389419 | Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system |
| Q48416513 | Adoptive transfer of T regulatory cells inhibits lipopolysaccharide-induced inflammation in fetal brain tissue in a late-pregnancy preterm birth mouse model |
| Q46266855 | Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease |
| Q33936858 | Association of matrix metalloproteinases with MRI indices of brain ischemia and aging |
| Q36873562 | Auxiliary KChIP4a suppresses A-type K+ current through endoplasmic reticulum (ER) retention and promoting closed-state inactivation of Kv4 channels |
| Q34364458 | CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice |
| Q36599172 | Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease |
| Q36782030 | Change in platelet endothelial cell adhesion molecule-1 immunoreactivity in the dentate gyrus in gerbils fed a folate-deficient diet |
| Q90251670 | Chronic sleep fragmentation shares similar pathogenesis with neurodegenerative diseases: Endosome-autophagosome-lysosome pathway dysfunction and microglia-mediated neuroinflammation |
| Q39423632 | Cognitive Frailty: Mechanisms, Tools to Measure, Prevention and Controversy |
| Q38366832 | Cognitive aspects of frailty: mechanisms behind the link between frailty and cognitive impairment. |
| Q34813794 | Correlation between serum RANTES levels and the severity of Parkinson's disease |
| Q34840113 | Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes |
| Q89823389 | Dangerous Liaison: Helicobacter pylori, Ganglionitis, and Myenteric Gastric Neurons: A Histopathological Study |
| Q29030707 | Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space |
| Q64093859 | Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes |
| Q91725226 | Dual-Channel Fluorescence Imaging of Hydrogel Degradation and Tissue Regeneration in the Brain |
| Q93115512 | ECMO attenuates inflammation response and increases ATPase activity in brain of swine model with cardiac arrest compared with CCPR |
| Q37765473 | Fingolimod is a potential novel therapy for multiple sclerosis |
| Q81429436 | Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury |
| Q28078211 | Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair |
| Q37668307 | In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging |
| Q41042662 | Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator. |
| Q37799890 | Inflammation and gliosis in neurological diseases – clinical implications |
| Q37987805 | Inflammation in neurological and psychiatric diseases |
| Q33942129 | Insulin alleviates the inflammatory response and oxidative stress injury in cerebral tissues in septic rats |
| Q51823592 | Interleukin-6 serum levels in patients with Parkinson's disease. |
| Q43035381 | Japanese encephalitis virus-infected macrophages induce neuronal death |
| Q48186929 | Microglia inflict delayed brain injury after subarachnoid hemorrhage. |
| Q28480940 | Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis |
| Q47566317 | Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases |
| Q37974560 | NSAIDs in the treatment and/or prevention of neurological disorders |
| Q63246147 | Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice |
| Q55344637 | Neural stem cell therapy for subacute and chronic ischemic stroke. |
| Q34727139 | Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here |
| Q34061851 | Neuroprotective properties of chitosan and its derivatives. |
| Q37057309 | New developments in understanding and treating neuroinflammation. |
| Q43838770 | Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system |
| Q41002202 | Orthodontic treatment for a patient with multiple sclerosis |
| Q39145017 | PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation. |
| Q47739408 | Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair |
| Q35496330 | Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders |
| Q48096610 | Protective Effect of Lupeol Against Lipopolysaccharide-Induced Neuroinflammation via the p38/c-Jun N-Terminal Kinase Pathway in the Adult Mouse Brain |
| Q57138614 | Removal of the Mitochondrial Fission Factor Mff Exacerbates Neuronal Loss and Neurological Phenotypes in a Huntington's Disease Mouse Model |
| Q61805979 | Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy |
| Q34144290 | Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials |
| Q33857753 | Selected acute phase CSF factors in ischemic stroke: findings and prognostic value |
| Q40544498 | Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults |
| Q28535065 | Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke |
| Q37081721 | T cells in amyotrophic lateral sclerosis |
| Q27329798 | Targeted ablation of oligodendrocytes triggers axonal damage |
| Q54288877 | Targeted delivery of a SNARE protease to sensory neurons using a single chain antibody (scFv) against the extracellular domain of P2X(3) inhibits the release of a pain mediator. |
| Q90227644 | The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD) |
| Q37153832 | The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model |
| Q37016245 | The immune response in Taenia solium cysticercosis: protection and injury |
| Q34331564 | The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf |
| Q87671063 | The role of TRAIL in fatigue induced by repeated stress from radiotherapy |
| Q38089599 | The role of natural killer cells in multiple sclerosis and their therapeutic implications |
| Q37839130 | Treating inflammation in childhood neurodegenerative disorders |
| Q53394507 | Will anti-amyloid therapies work for Alzheimer's disease? |
Search more.